Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers

BACKGROUND: Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs) may help restore limb perfusion in patients with diabetes mellitus and critical limb-threatening ischemia (CLTI) deemed not eligible for revascularization procedures and consequently at risk for major amputation (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Panunzi, Andrea, Madotto, Fabiana, Sangalli, Elena, Riccio, Federica, Sganzaroli, Adriana Barbara, Galenda, Paolo, Bertulessi, Amelia, Barmina, Maria Francesca, Ludovico, Ornella, Fortunato, Orazio, Setacci, Francesco, Airoldi, Flavio, Tavano, Davide, Giurato, Laura, Meloni, Marco, Uccioli, Luigi, Bruno, Antonino, Spinetti, Gaia, Caravaggi, Carlo Maria Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516816/
https://www.ncbi.nlm.nih.gov/pubmed/36171587
http://dx.doi.org/10.1186/s12933-022-01629-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516816/
https://www.ncbi.nlm.nih.gov/pubmed/36171587
http://dx.doi.org/10.1186/s12933-022-01629-y

Ejemplares similares